Syschem (India) Limited (BOM:531173)

Market Cap	2.23B +15.4%
Revenue (ttm)	5.45B +62.5%
Net Income	82.03M
EPS	1.47
Shares Out	43.51M
PE Ratio	34.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	114,319
Average Volume	40,401
Open	54.16
Previous Close	54.16
Day's Range	51.30 - 54.16
52-Week Range	35.33 - 62.00
Beta	-0.97
RSI	56.01
Earnings Date	Feb 2, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and ...

• Industry: Industrial Organic Chemicals
• Founded: 1993
• Employees: 115
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531173

Financial Performance

In fiscal year 2025, Syschem (India)'s revenue was 3.86 billion, an increase of 65.43% compared to the previous year's 2.33 billion. Earnings were 4.60 million, a decrease of -83.34%.